StatSure Diagnostic Systems, Inc.
Not enough financial coverage to compute a composite score for SSUR. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.statsurediagnostics.com
StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2.
- CEO
- Moshe Bodner
- IPO
- 1994
- Employees
- 4
- HQ
- Brooklyn, NY, US
Price Chart
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.42
- Avg Volume
- 0
Get TickerSpark's AI analysis on SSUR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SSUR Coverage
We haven't published any research on SSUR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SSUR Report →